These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15883908)
21. Novavax revealed preclinical data of virus-like particle HIV vaccine. Expert Rev Vaccines; 2007 Oct; 6(5):654-5. PubMed ID: 17931145 [No Abstract] [Full Text] [Related]
22. The role of CpG dinucleotides in DNA vaccines. Krieg AM; Yi AK; Schorr J; Davis HL Trends Microbiol; 1998 Jan; 6(1):23-7. PubMed ID: 9481820 [TBL] [Abstract][Full Text] [Related]
23. Drug target identification: a question of biology. Smith C Nature; 2004 Mar; 428(6979):225-31. PubMed ID: 15014514 [No Abstract] [Full Text] [Related]
24. An interview with Kenneth C. Lewis, Ph.D., CEO, and Joseph D. Simpkins, Vice President, Software, OpAns (Optimized Analytical Solutions), Durham, NC. Interview by Vicki Glaser. Lewis KC; Simpkins JD Assay Drug Dev Technol; 2007 Dec; 5(6):695-702. PubMed ID: 18181688 [No Abstract] [Full Text] [Related]
26. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Fuller DH; Loudon P; Schmaljohn C Methods; 2006 Sep; 40(1):86-97. PubMed ID: 16997717 [TBL] [Abstract][Full Text] [Related]
27. Preclinical drug discovery research and training at Vanderbilt. Lindsley CW; Weaver D; Jones C; Marnett L; Conn PJ ACS Chem Biol; 2007 Jan; 2(1):17-20. PubMed ID: 17243778 [No Abstract] [Full Text] [Related]
28. Assuring the quality, safety, and efficacy of DNA vaccines. Robertson JS; Griffiths E Methods Mol Med; 2006; 127():363-74. PubMed ID: 16988466 [TBL] [Abstract][Full Text] [Related]
29. Bringing DNA vaccines closer to commercial use. Carvalho JA; Prazeres DM; Monteiro GA IDrugs; 2009 Oct; 12(10):642-7. PubMed ID: 19790015 [TBL] [Abstract][Full Text] [Related]
30. The regulation of DNA vaccines. Smith HA; Klinman DM Curr Opin Biotechnol; 2001 Jun; 12(3):299-303. PubMed ID: 11404109 [TBL] [Abstract][Full Text] [Related]
31. "Spirit" of high throughput screening. Wesche H; Xiao SH; Young S Comb Chem High Throughput Screen; 2008 Mar; 11(3):174. PubMed ID: 18336210 [No Abstract] [Full Text] [Related]
32. The future of drug safety testing: expanding the view and narrowing the focus. Stevens JL; Baker TK Drug Discov Today; 2009 Feb; 14(3-4):162-7. PubMed ID: 19100337 [TBL] [Abstract][Full Text] [Related]
34. Emerging technologies for prediction of drug candidate efficacy in the preclinical pipeline. Menshykau D Drug Discov Today; 2017 Nov; 22(11):1598-1603. PubMed ID: 28545837 [TBL] [Abstract][Full Text] [Related]
35. Chemistry plans a structural overhaul. Russo E Nature; 2002 Sep; 419(6903):4-7. PubMed ID: 12226620 [No Abstract] [Full Text] [Related]
38. Real-time molecular and cellular analysis: the new frontier of drug discovery. Taylor DL; Woo ES; Giuliano KA Curr Opin Biotechnol; 2001 Feb; 12(1):75-81. PubMed ID: 11167077 [TBL] [Abstract][Full Text] [Related]
39. A testing approach based on tiny doses still awaits big results. Coombs A Nat Med; 2008 Aug; 14(8):796. PubMed ID: 18685584 [No Abstract] [Full Text] [Related]